药理学和非药理学调节儿科糖尿病的内质网膜应激
1Division of Pediatric Endocrinology, Department of Pediatrics, University Hospital of Patras, Patras, Greece.
Frontiers in endocrinology
|November 14, 2025
概括
儿科糖尿病涉及细胞内网膜 (ER) 的压力,影响胰腺β细胞功能. 针对ER压力提供了一个有希望的治疗策略,用于改善糖尿病儿童的代谢平衡和β细胞存活率.
科学领域:
- 内分泌学 在内分泌学.
- 细胞生物学 细胞生物学
- 儿科医学 儿科医学
背景情况:
- 细胞内膜网膜 (ER) 压力与所有儿科糖尿病类型的胰腺β细胞功能障碍和亡有关.
- 无论糖尿病亚型如何,ER反应完整性对于在胰岛素处理过程中管理压力至关重要.
- 人们越来越认识到ER压力是糖尿病发病的一个关键因素,而不仅仅是结果.
研究的目的:
- 探索所有形式的儿科糖尿病中ER压力的机制.
- 讨论调节ER压力的治疗策略,包括批准的儿科药物,如甲福林.
- 检查将ER应激调节与胰岛素治疗结合起来,以优化β细胞功能和生存.
主要方法:
- 文献综述,重点关注儿科糖尿病中ER压力机制.
- 对ER应力调节的药理和非药理方法的分析.
- 对维护β细胞的治疗潜力的检查.
主要成果:
- 在儿科糖尿病的发病过程中,ER压力通过影响β细胞功能和存活,起着重要作用.
- 针对ER压力是一个有希望的治疗途径.
- 甲胺和其他批准的儿科药物显示出调节ER压力的潜力.
结论:
- 调节ER压力是儿科糖尿病的关键治疗点.
- 将ER压力调节与胰岛素治疗结合起来,可以优化代谢平衡和β细胞健康.
- 对ER应激干预措施的进一步研究是有必要的,以改善儿科糖尿病管理.
相关概念视频
Role of ER in the Secretory Pathway
6.9K
Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
6.9K
Diabetes: Management and Pharmacotherapy
853
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
853
Pharmacokinetics in Pediatric Patients: Drug Metabolism
182
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.1K
Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K


